Moleculin Biotech, Inc. (MBRX) Operating income 2016–2025
Moleculin Biotech, Inc. (MBRX) annual operating income history from SEC filings — each fiscal year as reported.
-$25.1MFY2025 · since FY2016: -$3.9M → -$25.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.1M | +5.8% |
| FY2024 | -$26.6M | +10.1% |
| FY2023 | -$29.6M | +3.3% |
| FY2022 | -$30.6M | -33.4% |
| FY2021 | -$23.0M | -16.3% |
| FY2020 | -$19.7M | -12.7% |
| FY2019 | -$17.5M | -16.6% |
| FY2018 | -$15.0M | -73.6% |
| FY2017 | -$8.7M | -122.8% |
| FY2016 | -$3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice